Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.56 |
| ▸ | TSHR | P16473 | 5/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 2/20 | 0.32 |
| ▸ | PPARD | Q03181 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ether SCHEMBL989838 | 1.00 | ALDH1A1 (0.56) | ALDH1A1TSHRMAPK1THRBPPARD | |
| Ether SCHEMBL9639185 | 1.00 | ALDH1A1 (0.56) | ALDH1A1TSHRMAPK1THRBPPARD | |
| Ether SCHEMBL5483916 | 1.00 | ALDH1A1 (0.56) | ALDH1A1TSHRMAPK1THRBPPARD | |
| Ether SCHEMBL1173072 | 1.00 | ALDH1A1 (0.56) | ALDH1A1TSHRMAPK1THRBPPARD | |
| Ether SCHEMBL5575028 | 1.00 | ALDH1A1 (0.56) | ALDH1A1TSHRMAPK1THRBPPARD | |
| Ether SCHEMBL23356828 | 1.00 | ALDH1A1 (0.56) | ALDH1A1TSHRMAPK1THRBPPARD | |
| Ether SCHEMBL2582269 | 1.00 | ALDH1A1 (0.56) | ALDH1A1TSHRMAPK1THRBPPARD | |
| Ether SCHEMBL15741360 | 1.00 | ALDH1A1 (0.56) | ALDH1A1TSHRMAPK1THRBPPARD | |
| Ether SCHEMBL1419841 | 1.00 | ALDH1A1 (0.56) | ALDH1A1TSHRMAPK1THRBPPARD | |
| Ether SCHEMBL987826 | 1.00 | ALDH1A1 (0.56) | ALDH1A1TSHRMAPK1THRBPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 193 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250263546-A1 | ENDOLUMINAL DEVICE AND POLYMER | ENDOLOGIX LLC | 2025-08-21 | — | — | US | claimed |
| EP-3700465-B1 | ENDOLUMINAL DEVICE AND POLYMER | ENDOLOGIX LLC (US) | 2025-07-16 | — | — | EP | claimed |
| US-12240973-B2 | Endoluminal device and polymer | ENDOLOGIX LLC (US) | 2025-03-04 | — | — | US | claimed |
| US-20200324018-A1 | ENDOLUMINAL DEVICE AND POLYMER | SILICON VALLEY BANK | 2020-10-15 | — | — | US | claimed |
| EP-3700465-A1 | ENDOLUMINAL DEVICE AND POLYMER | Endologix, Inc. (US) | 2020-09-02 | — | — | EP | claimed |
| US-20170190670-A1 | IMPROVED PROCESS FOR THE PREPARATION OF ENZALUTAMIDE | SHILPA MEDICARE LIMITED (IN) | 2017-07-06 | — | — | US | claimed |
| EP-3166931-A1 | AN IMPROVED PROCESS FOR THE PREPARATION OF ENZALUTAMIDE | Shilpa Medicare Limited (IN) | 2017-05-17 | — | — | EP | claimed |
| WO-2016005875-A1 | AN IMPROVED PROCESS FOR THE PREPARATION OF ENZALUTAMIDE | SHILPA MEDICARE LIMITED (IN) | 2016-01-14 | — | — | WO | claimed |
| EP-1339282-B1 | HYDROPHILIC POLYMER BLENDS USED FOR DRY COW THERAPY | HYDROMER INC (US) | 2008-08-13 | — | — | EP | claimed |
| EP-1339282-A4 | HYDROPHILIC POLYMER BLENDS USED FOR DRY COW THERAPY | HYDROMER INC (US) | 2006-12-06 | — | — | EP | claimed |
| US-20030203821-A1 | Stable liquid suspension compositions and method of making | CHEVRON PHILLIPS CHEMICAL COMPANY LP | 2003-10-30 | — | — | US | claimed |
| EP-1339282-A1 | HYDROPHILIC POLYMER BLENDS USED FOR DRY COW THERAPY | Hydromer, Inc. (US) | 2003-09-03 | — | — | EP | claimed |
| US-6440442-B1 | FILM-FORMING TEAT DIP COMPRISING THERMOPLASTIC POLYURETHANE WITH NO REACTIVE ISOCYANATE GROUPS, POLY-N-VINYLLACTAM, MICROBIOCIDE BUFFER AND SOLVENT; REMOVABLE BY PEELING | HYDROMER, INC. | 2002-08-27 | — | — | US | claimed |
| WO-2002035931-A1 | HYDROPHILIC POLYMER BLENDS USED FOR DRY COW THERAPY | HYDROMER, INC. (US) | 2002-05-10 | — | — | WO | claimed |
| US-6264800-B1 | Purification process | ARCO CHEMICAL TECHNOLOGY, L.P. | 2001-07-24 | — | — | US | claimed |
| US-4847324-A | Hydrophilic polyvinylbutyral alloys | HYDROMER, INC. (US) | 1989-07-11 | — | — | US | claimed |
| US-12637578-B2 | Ink jet ink composition and recording method | SEIKO EPSON CORPORATION (JP) | 2026-05-26 | — | — | US | disclosed |
| US-12527733-B2 | Fragrance compositions | ELC MANAGEMENT LLC (US) | 2026-01-20 | — | — | US | disclosed |
| US-4345058-A | Urethane prepolymer repair system | THE THEODORE J. AND MARIYLN J. DETTLING, MARCH 9, 1990 FAMILY TRUST | 1982-08-17 | — | — | US | disclosed |
| US-4321184-A | FROM OXIDATED SILICON COMPOUNDS AND SUBSTITUTED ORGANIC COMPOUND IN PORESENCE OF AN ALKALI COMPOUND | BLOUNT DAVID H | 1982-03-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12637578-B2 | Ink jet ink composition and recording method | TYR, RB1, WNT1 | ALDH1A1 963/4885TSHR 3228/4885MAPK1 394/4885 |
| US-12527733-B2 | Fragrance compositions | CUTA, IL36G, TAS2R40 | ALDH1A1 384/4885TSHR 3331/4885MAPK1 3588/4885 |
| US-20170190670-A1 | IMPROVED PROCESS FOR THE PREPARATION OF ENZALUTAMIDE | KLK3, AR, KLK5 | ALDH1A1 636/4885TSHR 4148/4885MAPK1 3320/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.